본문으로 건너뛰기
← 뒤로

PSMA PET/CT in Detecting Esophageal Cancer and Hepatocellular Carcinoma. A Report of Two Cases.

1/5 보강
Clinical nuclear medicine 📖 저널 OA 3.9% 2021: 0/2 OA 2022: 1/12 OA 2023: 0/8 OA 2024: 0/22 OA 2025: 3/79 OA 2026: 5/104 OA 2021~2026 2025 Vol.50(10) p. 963-965
Retraction 확인
출처

Chatta R, Shah H, Pallod S

📝 환자 설명용 한 줄

Prostate-specific membrane antigen (PSMA) PET/CT has improved the diagnosis, staging, and detection of recurrent and metastatic prostate cancer.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Chatta R, Shah H, Pallod S (2025). PSMA PET/CT in Detecting Esophageal Cancer and Hepatocellular Carcinoma. A Report of Two Cases.. Clinical nuclear medicine, 50(10), 963-965. https://doi.org/10.1097/RLU.0000000000005901
MLA Chatta R, et al.. "PSMA PET/CT in Detecting Esophageal Cancer and Hepatocellular Carcinoma. A Report of Two Cases.." Clinical nuclear medicine, vol. 50, no. 10, 2025, pp. 963-965.
PMID 40247467 ↗

Abstract

Prostate-specific membrane antigen (PSMA) PET/CT has improved the diagnosis, staging, and detection of recurrent and metastatic prostate cancer. Nevertheless, PSMA uptake has also been observed in non-prostatic conditions, which underscores the need to explore its broader applications and refine our understanding of its specificity in diverse clinical contexts. In cases of uptake in atypical locations, further workup is warranted to avoid premature conclusions of metastatic prostate disease. We report two cases of PSMA PET uptake: the first involves esophageal cancer, and the second details two synchronous malignancies-hepatocellular and esophageal cancer.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반